首页 | 本学科首页   官方微博 | 高级检索  
     


The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era
Authors:Sandy T. Liu  Gavin Hui  Colleen Mathis  Karim Chamie  Allan J. Pantuck  Alexandra Drakaki
Affiliation:1. Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA;2. David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA;3. Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA;4. Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA
Abstract:
Keywords:Bladder cancer  Inhibitors  mTOR  PI3K  Targeted therapy
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号